Baumer

Baumer SG&A Expenses

The Selling, General & Administrative Expenses of Baumer (BALM4.SA) as of Nov 9, 2026 is 85.00 M BRL. In the previous year, Selling, General & Administrative Expenses was 74.00 M BRL — a change of 14.86% (higher).

SG&A Expenses

85.00 MBRL

YoY

14.86%

Last updated:

Selling, General & Administrative Expenses of Baumer is 2024 85.00 M BRL. Selling, General & Administrative Expenses of Baumer was 2023 74.00 M BRL. It decreases by 14.86% higher compared to the previous year.

The Baumer SG&A Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SG&A Expenses
Date
SG&A Expenses
Jan 1, 2017
53.01 M BRL
Jan 1, 2018
56.31 M BRL
Jan 1, 2019
61.23 M BRL
Jan 1, 2020
58.06 M BRL
Jan 1, 2021
62.14 M BRL
Jan 1, 2022
67.11 M BRL
Jan 1, 2023
74.00 M BRL
Jan 1, 2024
85.00 M BRL
The Baumer SG&A Expenses history
YEARSG&A ExpensesYoY
85.00 MBRL+14.86%
74.00 MBRL+10.26%
67.11 MBRL+8.01%
62.14 MBRL+7.02%
58.06 MBRL-5.18%
61.23 MBRL+8.74%
56.31 MBRL+6.22%
53.01 MBRL-0.63%
53.35 MBRL+15.11%
46.34 MBRL-5.41%
49.00 MBRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Selling, General & Administrative Expenses of Baumer is 85.00 M BRL in 2024.

Selling, General & Administrative Expenses of Baumer changed from 74.00 M BRL to 85.00 M BRL, representing a 14.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Selling, General & Administrative Expenses Baumer since 2006 – with annual values, charts, and detailed analysis.

SG&A expenses include all non-production costs such as salaries, marketing, rent, and administrative overhead. They are a key component of operating expenses.

Selling, General & Administrative Expenses's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Selling, General & Administrative Expenses's Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Baumer

All Key Metrics — Baumer